The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme
- PMID: 15158118
- DOI: 10.1016/j.yjmcc.2004.02.013
The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme
Abstract
The resin angiotensin system (RAS) plays an essential role in blood pressure regulation and electrolyte homeostasis. The effecter peptide of the RAS, angiotensin II, is produced by angiotensin converting enzyme (ACE) in multiple tissues. Genetic deletion of ACE in mice resulted a phenotype of low blood pressure, anemia and kidney defects. However, it is not clear whether the lack of the systemic or the local production of angiotensin II caused these defects. To understand the role of local angiotensin II production, we developed a method to achieve tissue specific ACE expression through homologous recombination. In this review, we discuss mouse models in which endothelial ACE was eliminated and replaced by hepatic ACE. These studies suggest that both circulating angiotensin II and local angiotensin II production play a role in angiotensin II generation; the elimination of local angiotensin II generation up-regulates systemic production and maintains physiologic homeostasis.
Similar articles
-
Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE).Crit Rev Eukaryot Gene Expr. 2004;14(1-2):137-45. Crit Rev Eukaryot Gene Expr. 2004. PMID: 15104531 Review.
-
New approaches to genetic manipulation of mice: tissue-specific expression of ACE.Am J Physiol Renal Physiol. 2003 Apr;284(4):F599-607. doi: 10.1152/ajprenal.00308.2002. Am J Physiol Renal Physiol. 2003. PMID: 12620918 Review.
-
Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.J Surg Res. 2005 Dec;129(2):272-7. doi: 10.1016/j.jss.2005.04.044. Epub 2005 Jun 29. J Surg Res. 2005. PMID: 15992826
-
Development of domain-selective angiotensin I-converting enzyme inhibitors.Ann N Y Acad Sci. 2005 Nov;1056:160-75. doi: 10.1196/annals.1352.035. Ann N Y Acad Sci. 2005. PMID: 16387685
-
N-Domain angiotensin I-converting enzyme expression in renal artery of Wistar, Wistar Kyoto, and spontaneously hypertensive rats.Transplant Proc. 2004 May;36(4):1001-3. doi: 10.1016/j.transproceed.2004.03.081. Transplant Proc. 2004. PMID: 15194348
Cited by
-
RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.Cardiorenal Med. 2012 Dec;2(4):268-280. doi: 10.1159/000343456. Epub 2012 Oct 27. Cardiorenal Med. 2012. PMID: 23381810 Free PMC article.
-
Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.Exp Physiol. 2008 May;93(5):685-93. doi: 10.1113/expphysiol.2007.040352. Epub 2008 Jan 25. Exp Physiol. 2008. PMID: 18223027 Free PMC article.
-
A role for the renin-angiotensin system in hematopoiesis.Haematologica. 2009 Jun;94(6):745-7. doi: 10.3324/haematol.2009.006965. Haematologica. 2009. PMID: 19483149 Free PMC article. No abstract available.
-
Nontraditional roles of angiotensin-converting enzyme.Hypertension. 2012 Apr;59(4):763-8. doi: 10.1161/HYPERTENSIONAHA.111.188342. Epub 2012 Feb 21. Hypertension. 2012. PMID: 22353608 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous